1. Home
  2. BRTX vs ANY Comparison

BRTX vs ANY Comparison

Compare BRTX & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • ANY
  • Stock Information
  • Founded
  • BRTX 1997
  • ANY N/A
  • Country
  • BRTX United States
  • ANY United States
  • Employees
  • BRTX N/A
  • ANY N/A
  • Industry
  • BRTX Managed Health Care
  • ANY Finance: Consumer Services
  • Sector
  • BRTX Health Care
  • ANY Finance
  • Exchange
  • BRTX Nasdaq
  • ANY Nasdaq
  • Market Cap
  • BRTX 11.2M
  • ANY 12.2M
  • IPO Year
  • BRTX N/A
  • ANY N/A
  • Fundamental
  • Price
  • BRTX $1.85
  • ANY $0.55
  • Analyst Decision
  • BRTX Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • BRTX 1
  • ANY 1
  • Target Price
  • BRTX $18.00
  • ANY $3.00
  • AVG Volume (30 Days)
  • BRTX 48.0K
  • ANY 258.8K
  • Earning Date
  • BRTX 03-27-2025
  • ANY 05-12-2025
  • Dividend Yield
  • BRTX N/A
  • ANY N/A
  • EPS Growth
  • BRTX N/A
  • ANY N/A
  • EPS
  • BRTX N/A
  • ANY N/A
  • Revenue
  • BRTX $401,000.00
  • ANY $16,608,000.00
  • Revenue This Year
  • BRTX $482.76
  • ANY N/A
  • Revenue Next Year
  • BRTX $212.24
  • ANY N/A
  • P/E Ratio
  • BRTX N/A
  • ANY N/A
  • Revenue Growth
  • BRTX 175.03
  • ANY N/A
  • 52 Week Low
  • BRTX $1.03
  • ANY $0.38
  • 52 Week High
  • BRTX $2.55
  • ANY $1.90
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 53.36
  • ANY 51.73
  • Support Level
  • BRTX $1.72
  • ANY $0.38
  • Resistance Level
  • BRTX $1.85
  • ANY $0.47
  • Average True Range (ATR)
  • BRTX 0.13
  • ANY 0.05
  • MACD
  • BRTX 0.02
  • ANY 0.01
  • Stochastic Oscillator
  • BRTX 50.98
  • ANY 96.94

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: